These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

367 related items for PubMed ID: 32446183

  • 1. Tackling the overdose crisis: The role of safe supply.
    Ivsins A, Boyd J, Beletsky L, McNeil R.
    Int J Drug Policy; 2020 Jun; 80():102769. PubMed ID: 32446183
    [Abstract] [Full Text] [Related]

  • 2. Barriers and facilitators to a novel low-barrier hydromorphone distribution program in Vancouver, Canada: a qualitative study.
    Ivsins A, Boyd J, Mayer S, Collins A, Sutherland C, Kerr T, McNeil R.
    Drug Alcohol Depend; 2020 Nov 01; 216():108202. PubMed ID: 32948372
    [Abstract] [Full Text] [Related]

  • 3. An individual-based dynamic model to assess interventions to mitigate opioid overdose risk.
    Gallant K, Lukeman R.
    Harm Reduct J; 2024 Aug 13; 21(1):146. PubMed ID: 39135022
    [Abstract] [Full Text] [Related]

  • 4. "It's Helped Me a Lot, Just Like to Stay Alive": a Qualitative Analysis of Outcomes of a Novel Hydromorphone Tablet Distribution Program in Vancouver, Canada.
    Ivsins A, Boyd J, Mayer S, Collins A, Sutherland C, Kerr T, McNeil R.
    J Urban Health; 2021 Feb 13; 98(1):59-69. PubMed ID: 33118145
    [Abstract] [Full Text] [Related]

  • 5. Community partner perspectives on the implementation of a novel safer supply program in Canada: a qualitative study of the MySafe Project.
    Mansoor M, Foreman-Mackey A, Ivsins A, Bardwell G.
    Harm Reduct J; 2023 Apr 28; 20(1):61. PubMed ID: 37118799
    [Abstract] [Full Text] [Related]

  • 6. Distribution of take-home opioid antagonist kits during a synthetic opioid epidemic in British Columbia, Canada: a modelling study.
    Irvine MA, Buxton JA, Otterstatter M, Balshaw R, Gustafson R, Tyndall M, Kendall P, Kerr T, Gilbert M, Coombs D.
    Lancet Public Health; 2018 May 28; 3(5):e218-e225. PubMed ID: 29678561
    [Abstract] [Full Text] [Related]

  • 7. Modelling the combined impact of interventions in averting deaths during a synthetic-opioid overdose epidemic.
    Irvine MA, Kuo M, Buxton JA, Balshaw R, Otterstatter M, Macdougall L, Milloy MJ, Bharmal A, Henry B, Tyndall M, Coombs D, Gilbert M.
    Addiction; 2019 Sep 28; 114(9):1602-1613. PubMed ID: 31166621
    [Abstract] [Full Text] [Related]

  • 8. Responding to a surge in overdose deaths: perspectives from US syringe services programs.
    Frost MC, Austin EJ, Corcorran MA, Briggs ES, Behrends CN, Juarez AM, Frank ND, Healy E, Prohaska SM, LaKosky PA, Kapadia SN, Perlman DC, Schackman BR, Des Jarlais DC, Williams EC, Glick SN.
    Harm Reduct J; 2022 Jul 19; 19(1):79. PubMed ID: 35854351
    [Abstract] [Full Text] [Related]

  • 9. "I Don't Go Overboard": Perceptions of Overdose Risk and Risk Reduction Strategies among People Who Use Drugs in Rhode Island.
    Collins AB, Kaplowitz E, Bastani P, McKee H, Whitaker D, Hallowell BD, McKenzie M.
    Subst Use Misuse; 2024 Jul 19; 59(5):673-679. PubMed ID: 38124349
    [Abstract] [Full Text] [Related]

  • 10. The Opioid Epidemic: Task-Shifting in Health Care and the Case for Access to Harm Reduction for People Who Use Drugs.
    Jozaghi E.
    Int J Health Serv; 2022 Apr 19; 52(2):261-268. PubMed ID: 32268811
    [Abstract] [Full Text] [Related]

  • 11. Housing and overdose: an opportunity for the scale-up of overdose prevention interventions?
    Bardwell G, Collins AB, McNeil R, Boyd J.
    Harm Reduct J; 2017 Dec 06; 14(1):77. PubMed ID: 29212507
    [Abstract] [Full Text] [Related]

  • 12. Stronger, longer, better opioid antagonists? Nalmefene is NOT a naloxone replacement.
    Infante AF, Elmes AT, Gimbar RP, Messmer SE, Neeb C, Jarrett JB.
    Int J Drug Policy; 2024 Feb 06; 124():104323. PubMed ID: 38232438
    [Abstract] [Full Text] [Related]

  • 13. Losing the uphill battle? Emergent harm reduction interventions and barriers during the opioid overdose crisis in Canada.
    Strike C, Watson TM.
    Int J Drug Policy; 2019 Sep 06; 71():178-182. PubMed ID: 30975595
    [Abstract] [Full Text] [Related]

  • 14. Risk mitigation guidance and safer supply prescribing among young people who use drugs in the context of COVID-19 and overdose emergencies.
    Giang K, Charlesworth R, Thulien M, Mulholland A, Barker B, Brar R, Pauly B, Fast D.
    Int J Drug Policy; 2023 May 06; 115():104023. PubMed ID: 37059025
    [Abstract] [Full Text] [Related]

  • 15. Strategies used to reduce harms associated with fentanyl exposure among rural people who use drugs: multi-site qualitative findings from the rural opioid initiative.
    Walters SM, Baker R, Frank D, Fadanelli M, Rudolph AE, Zule W, Fredericksen RJ, Bolinski R, Sibley AL, Go VF, Ouellet LJ, Pho MT, Seal DW, Feinberg J, Smith G, Young AM, Stopka TJ.
    Harm Reduct J; 2024 Aug 24; 21(1):154. PubMed ID: 39182116
    [Abstract] [Full Text] [Related]

  • 16. Investigating opioid preference to inform safe supply services: A cross sectional study.
    Ferguson M, Parmar A, Papamihali K, Weng A, Lock K, Buxton JA.
    Int J Drug Policy; 2022 Mar 24; 101():103574. PubMed ID: 35007878
    [Abstract] [Full Text] [Related]

  • 17. Characterizing prescription opioid, heroin, and fentanyl initiation trajectories: A qualitative study.
    Perdue T, Carlson R, Daniulaityte R, Silverstein SM, Bluthenthal RN, Valdez A, Cepeda A.
    Soc Sci Med; 2024 Jan 24; 340():116441. PubMed ID: 38061222
    [Abstract] [Full Text] [Related]

  • 18. The Public Health Approach to the Worsening Opioid Crisis in the United States Calls for Harm Reduction Strategies to Mitigate the Harm From Opioid Addiction and Overdose Deaths.
    Yeo Y, Johnson R, Heng C.
    Mil Med; 2022 Aug 25; 187(9-10):244-247. PubMed ID: 34908134
    [Abstract] [Full Text] [Related]

  • 19. Gaps in naloxone ownership among people who inject drugs during the fentanyl wave of the opioid overdose epidemic in New York City, 2018.
    Rivera AV, Nolan ML, Paone D, Carrillo SA, Braunstein SL.
    Subst Abus; 2022 Aug 25; 43(1):1172-1179. PubMed ID: 35617642
    [Abstract] [Full Text] [Related]

  • 20. Characterizing fentanyl-related overdoses and implications for overdose response: Findings from a rapid ethnographic study in Vancouver, Canada.
    Mayer S, Boyd J, Collins A, Kennedy MC, Fairbairn N, McNeil R.
    Drug Alcohol Depend; 2018 Dec 01; 193():69-74. PubMed ID: 30343236
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.